Pular para o conteúdo principal
Ranking Invest

TEM - Tempus AI, Inc.

Segmento: HealthcareTempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Análise Ranking Invest

Valuation estimado
-$ 782.55 Mi
Valor de Mercado
$ 10.71 Bi
Desconto (AV)-1469.1%
IVR
-0.07A companhia vale -0,07 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
-0.12O valuation alternativo equivale a -12% do valor de mercado da companhia.
MLL
-0.12O lucro líquido dos controladores em 16 trimestres equivale a -12% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 444.93 Mi

Dívida Líquida

-$ 599.61 Mi

L4T

-$ 254.43 Mi

MM4T

-18.34%

Indicadores Básicos

ROE

-57.18%

Índices de Previsibilidade

Receita Líquida

E0.14

Lucro

C0.33

Margem

C0.44

Índices de Tendência

Receita Líquida

A11.46

Lucro

D0.32

Margem

A10.42

Índices de Endividamento

DIV/PAT

-1.35

DIV/L4T

2.36

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.